CorrespondenceOptimal dosing of antidepressant drugs – Authors' reply
References (10)
- et al.
Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis
Lancet Psychiatry
(2019) - et al.
Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis
Lancet Psychiatry
(2019) - et al.
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
Lancet
(2018) - et al.
Worldwide distribution of cytochrome P450 alleles: a meta-analysis of population-scale sequencing projects
Clin Pharmacol Ther
(2017) - et al.
A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in Japan
Int Clin Psychopharmacol
(2016)
There are more references available in the full text version of this article.
Cited by (1)
Analysis of time-course, dose-effect, and influencing factors of antidepressants in the treatment of acute adult patients with major depression
2021, International Journal of Neuropsychopharmacology
© 2019 Elsevier Ltd. All rights reserved.